Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: A prospective study

Alimentary Pharmacology and Therapeutics

Volumn 17, Issue 8, 2003, Pages 1031-1037

  Hezode C ^a   Lonjon, I ^a   Roudot Thoraval, F ^a   Pawlotsky, J M ^a   Zafrani, E S ^a   Dhumeaux, D ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE EXACERBATION; DISEASE SEVERITY; EVALUATION; FEMALE; HEPATITIS C; HUMAN; LIVER FIBROSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SEX DIFFERENCE; STEATOSIS;

ADULT; ALCOHOL DRINKING; DISEASE PROGRESSION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0038707215     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01546.x     Document Type: Article

References (33)

1. EASL International Consensus Conference on Hepatitis C. Consensus statement. J Hepatol 1999; 30: 956-61.
2. Roudot-Thoraval F, Pawlotsky JM, Deforges L, Girollet PP, Dhumeaux D. Anti-HCV seroprevalence in pregnant women in France. Gut 1993; 34(Suppl.): S55-6.
3. Kiyosawa K, Tanaka E, Sodeyama T, et al. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. Gastroenterology 1994; 106: 1596-602.
4. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-6.
5. Seef LB, Miller RN, Rabkin CS, et al. 45-years follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000; 132: 105-11.
6. Roudot-Thoraval F, Bastie A, Pawlotsky JM, Dhumeaux D. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. Hepatology 1997; 26: 485-90.
7. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995; 171: 1607-10.
8. Zeuzem S, Franke A, Lee JH, Herrmann G, Ruster B, Roth WK. Phylogenic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests and histology. Hepatology 1996; 24: 1003-9.
9. Cromie SL, Jenkins PJ, Bowden DS, Dudley FJ. Chronic hepatitis C: effect of alcohol on hepatic activity and viral titre. J Hepatol 1996; 25: 821-6.
10. Corrao G, Arico S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology 1998; 27: 914-9.
11. Pessione F, Degos F, Marcellin P, et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 1998; 27: 1717-22.
12. Ostapowicz G, Watson KJ, Locarnini SA, Desmond PV. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 1998; 27: 1730-5.
13. Wiley TE, McCarthy M, Breidi L, McCarthy M, Layden TJ. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 1998; 28: 805-9.
14. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variation in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
15. Bedossa P, Poynard T, for the METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289-93.
16. Williams GD, Proudfit AH, Quinn EA, Campbell KE. Variations in quantity-frequency measures of alcohol consumption from a general population survey. Workshop on measurement issues in alcohol consumption. Addiction 1994; 89: 413-20.
17. Poynard T, Bedossa P, Opolon P, for the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC Groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C, Lancet 1997; 349: 825-32.
18. Parés A, Caballeria J, Bruguera M, Torres M, Rodés J. Histological course of alcoholic hepatitis: influence of abstinence, sex, and extent of hepatic damage. J Hepatol 1986; 2: 33-42.
19. Becker U, Deis A, Sorensen TI, et al. Prediction of risk of liver disease by alcohol intake, sex and age: a prospective population study. Hepatology 1996; 26: 1025-8.
20. Oshita M, Hayashi N, Kasahara A, et al. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology 1994; 20: 1115-20.
21. Smith WI, Van Thiel DH, Whiteside T, et al. Altered immunity in male patients with alcoholic liver disease: evidence for defective immune regulation. Alcoholism 1980; 4: 199-206.
22. Bagasra O, Howeedy A, Dorio R, Kajdacsy-Balla A. Functional analysis of T-cell subsets in chronic experimental alcoholism. Immunology 1987; 61: 63-9.
23. Geissler M, Gesien A, Wands JR. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids. J Immunol 1997; 159: 5107-13.
24. Hourigan LF, Macdonald GA, Purdie D, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999; 29: 1215-9.
25. Adinolfi LE, Gambardella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33: 1358-64.
26. Hakamada K, Sasaki M, Takahashi K, Umehara Y, Konn M. Sinusoidal flow block after warm ischemia in rats with diet-induced fatty liver. J Surg Res 1997; 70: 12-20.
27. Day C, James O. Hepatic steatosis: innocent bystander or guilty party? Hepatology 1998; 27: 1463-6.
28. Fromenty B, Pessayre D. Impaired mitochondrial function in microvesicular steatosis. J Hepatol 1997; 26: 43-53.
29. Rashid A, Wu TC, Huang CC, et al. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 1999; 29: 1131-8.
30. Selzner M, Clavien PA. Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology 2000; 31: 35-42.
31. Negro F, Hepatitis C virus and liver steatosis: is it the virus? Yes it is, but not always. Hepatology 2002; 36: 1050-2.
32. Moriya K, Yotsuyanagi H, Shintani Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997; 78: 1527-31.
33. Adinolfi LE, Utili R, Ruggiero G. Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients. Hepatology 1999; 30: 1530-1.